Polar Capital Funds PLC - Polar Capital Healthcare Blue Chip Fund I Accumulation (GBP)Register to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 4.5 | 23.5 | 6.0 | 0.1 | 10.5 | |
+/-Cat | -13.0 | 14.1 | 10.7 | 3.3 | 5.3 | |
+/-B’mrk | - | 5.3 | 0.2 | 2.7 | 2.5 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 24/04/2024 | GBP 16.62 | |
Day Change | -0.36% | |
Morningstar Category™ | Sector Equity Healthcare | |
IA (formerly IMA) Sector | Healthcare | |
ISIN | IE00BPRBXV28 | |
Fund Size (Mil) 24/04/2024 | USD 257.33 | |
Share Class Size (Mil) 24/04/2024 | USD 93.38 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 31/12/2023 | 0.97% |
Investment Objective: Polar Capital Funds PLC - Polar Capital Healthcare Blue Chip Fund I Accumulation (GBP) |
The Fund’s investment objective is to achieve long term capital appreciation. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
James Douglas 01/09/2015 | ||
Inception Date 11/09/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Polar Capital Funds PLC - Polar Capital Healthcare Blue Chip Fund I Accumulation (GBP) | 29/02/2024 |
|
|
Top 5 Holdings | Sector | % |
Eli Lilly and Co | Healthcare | 7.48 |
AbbVie Inc | Healthcare | 5.96 |
Elevance Health Inc | Healthcare | 5.28 |
Novartis AG Registered Shares | Healthcare | 5.03 |
Abbott Laboratories | Healthcare | 4.52 |
Increase Decrease New since last portfolio | ||
Polar Capital Funds PLC - Polar Capital Healthcare Blue Chip Fund I Accumulation (GBP) |